FDA officials said J&J’s regulatory submission for its planned booster raised red flags including small sample sizes and data based on tests that had not been validated. Photo: AP FDA officials said J&J’s regulatory submission for its planned booster raised red flags including small sample sizes and data based on tests that had not been validated. Photo: AP
FDA officials said J&J’s regulatory submission for its planned booster raised red flags including small sample sizes and data based on tests that had not been validated. Photo: AP

Johnson & Johnson coronavirus vaccine gets better boost from Moderna or Pfizer, US study shows

  • The findings by the National Institutes of Health come as an advisory group to the FDA prepares to discuss booster jabs for Moderna and J&J vaccines
  • The preliminary study also showed that ‘mixing and matching’ booster shots of different types is safe in adults

Topic |   Coronavirus pandemic
FDA officials said J&J’s regulatory submission for its planned booster raised red flags including small sample sizes and data based on tests that had not been validated. Photo: AP FDA officials said J&J’s regulatory submission for its planned booster raised red flags including small sample sizes and data based on tests that had not been validated. Photo: AP
FDA officials said J&J’s regulatory submission for its planned booster raised red flags including small sample sizes and data based on tests that had not been validated. Photo: AP
READ FULL ARTICLE